
Reglagene’s Breakthrough Brain Cancer Therapy Earns Dual Recognition in Top Oncology Publications
Encouraging reports showcase RGN6024's powerful response to deadliest brain cancer HOUSTON, TX, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Reglagene, Inc., a biotechnology company developing novel therapeutics for cancer, has received …